Backgrounds/Aims: By reviewing difficult resections for advanced hepatic malignancies, we discuss the effectiveness and extended indications for hepatectomy in such patients. Methods: We reviewed 7 patients who underwent extensive surgery between July 2008 and March 2011 for advanced hepatic malignancies. They had stage IV disease, except for in one case that was a stage IIIC (T4N0M0) hepatocellular carcinoma (HCC). Results: Patient 1 with intrahepatic cholangiocarcinoma (IHCC) underwent right hemihepatectomy and resection of the bile duct and left portal vein. At 39 months after surgery, she had no recurrence or metastasis. Patient 2 with HCC underwent palliative right trisectionectomy. At 38 months after surgery, he is alive despite residual pulmonary metastases. Patient 3 with HCC invading the hepatic vein and diaphragm underwent right trisectionectomy and caval venoplasty. At 12 months after surgery, he had no recurrence or metastasis. Patient 4, who had 2 large HCCs and pulmonary thromboembolism, underwent a right trisectionectomy. At 7 months after surgery, he had no evidence of recurred HCC. Patient 5, who had IHCC invading her inferior vena cava and main portal vein, underwent preoperative radiotherapy, left hemihepatectomy, and caval resection. At 20 months after surgery, she is well despite a caval thrombus. Patient 6 and 7 underwent repeated surgery due to a recurred IHCC and metastatic colon cancer, respectively. In addition, they are alive during each 20 and 17 months after surgery. Conclusions: Despite macroscopic extrahepatic metastases or major vessel involvement, extensive surgery for advanced hepatic malignancy may result in relatively favorable outcomes and be important modality for improving of survival in such patients. 
INTRODUCTION
Cure of hepatic malignancy is deemed possible only if the tumor can be completely resected. However, it is difficult to resect an advanced hepatic malignancy that is huge and tightly invasive or adherent to adjacent organs, especially the inferior vena cava (IVC), hepatic vein, and diaphragm. The prognosis of the patient with primary liver cancer is dependent on the tumor stage, the degree of liver function impairment, and the underlying cirrhosis. 
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Recent reports have shown, however, that aggressive surgery may improve survival rates in patients with advanced HCC, even in the presence of poor prognostic factors, such as portal vein thrombosis or bilobar tumors. 4, 7, 8 OS, overall survival; DFS, disease-free survival; IHCC, intrahepatic cholangiocarcinoma; HCC, hepatocellular carcinoma; RH, right hemihepatectomy; LND, lymph node dissection; pRTS, palliative right trisectionectomy; HV, hepatic vein; RTS, right trisectionectomy; TVE, total vascular exclusion; IVC, inferior vena cava; PTE, pulmonary thromboembolism; LH, left hemihepatectomy; AR, anterior resection; PH, partial hepatectomy; RTx, radiotherapy; TACI, transarterial chemoinfusion; CTx, chemotherapy; Op, operation.
Similarly, salvage surgery following tumor down-staging with systemic chemotherapy and/or regional therapy has been reported to result in low operative mortality and morbidity and to provide better long-term outcomes, [9] [10] [11] we described here.
Seven patients who underwent difficult resections for advanced tumors with multiple metastases, invasion of adjacent organs, or pulmonary embolism, have experienced favorable outcomes. We also discuss the extension of indications for hepatectomy in patients with advanced hepatic malignancies.
METHODS
We describe 7 patients who underwent palliative or ex- Table 1 . (Fig. 1A, B) . His serum AFP concentration was 298,000 ng/ml. He had started to take sorafenib at the time of diagnosis and underwent TACE before 
Patient 5
Patient 5 was a 45-year-old previous healthy woman with a 5 cm-sized IHCC in the caudate lobe and invasion of the IVC and main portal vein ( Fig. 2A, B) . At the time of diagnosis, her CA19-9 level was 88.6 U/ml. After 1 month of preoperative chemo-and radio-therapy, she underwent a left trisectionectomy and resection of the IVC.
During the operation, we resected the IVC which had been invaded by the tumor, followed by an anastomosis by interpositioning the graft with total vascular exclusion ( Fig. 2C-G) . Pathologic examination showed that the tumor was a mass forming type of cholangiocarcinoma, measuring 5.8×5.0×4.2 cm with poor differentiation and invading the IVC (Fig. 2H) . Twenty months after surgery, this patient showed no evidence of recurrence or metastases despite an IVC thrombus with venous congestion.
The patient is currently receiving anticoagulation therapy and was waiting for a thrombectomy. 
Patient 7
Patient 7 was a 49-year-old man who had previously undergone surgery for colon cancer with liver metastasis, consisting of palliative right hemihepatectomy and caudate lobectomy, diaphragm resection, and anterior resection of the colon. However, the metastatic mass in the liver recurred twice at 1-year intervals, for which the patient underwent repeated resections, followed by 34 doses of chemotherapy. At 17 months after last surgery, he remained free from cancer.
DISCUSSION
Identification of the optimal therapeutic approach to pa- Although all 7 of these patients described here had ad- This study had several limitations, including retrospective design and a small number of patients. Thus, it is difficult to determine an overall strategy to treat heterogeneous types of advanced hepatic malignancies. Moreover, it would be difficult to perform a randomized controlled trial of these patients. Another limitation was the heterogeneity of this group of patients. However, selecting groups of patients with the same stage or disease entity may yield more consistent results.
In highly selected patients with stage 3 or 4 hepatic malignancies, aggressive surgical approaches may prolong survival, while maintaining a good quality of life, despite residual macroscopic intra-or extrahepatic metastases.
Surgery remains the key therapeutic modality to treat the patients with advanced hepatic malignancies.
